# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA5191897 | Q-a2 | K | = | 0.009 | /s | ALA5143809 | /s | Human immunodeficiency virus 1 | |||
2. | ALA5191897 | Q-a2 | Stability | = | 96.5 | % | ALA5143806 | % | ||||
3. | ALA5191897 | Q-a2 | Stability | = | 104.7 | % | ALA5143805 | % | ||||
4. | ALA5191897 | Q-a2 | Stability | = | 0 | % | ALA5143804 | % | ||||
5. | ALA5191897 | Q-a2 | CLH | = | 843.9 | microL/min/mg | ALA5143803 | mL.min-1.g-1 | ||||
6. | ALA5191897 | Q-a2 | t1/2 | = | 1.6 | min | ALA5143802 | hr | ||||
7. | ALA5191897 | Q-a2 | Ratio | = | 0.98 | ALA5143797 | ||||||
8. | ALA5191897 | Q-a2 | Kd | = | 7.2 | uM | ALA5143796 | 5.14 | nM | Human immunodeficiency virus 1 | ||
9. | ALA5191897 | Q-a2 | Kd | = | 6.42 | uM | ALA5143795 | 5.19 | nM | Human immunodeficiency virus 1 | ||
10. | ALA5191897 | Q-a2 | Ratio CC50/EC50 | = | 3.1 | ALA5143794 | ||||||
11. | ALA5191897 | Q-a2 | Ratio CC50/EC50 | = | 19.33 | ALA5143793 | ||||||
12. | ALA5191897 | Q-a2 | CC50 | = | 13.34 | uM | ALA5143792 | nM | Homo sapiens | |||
13. | ALA5191897 | Q-a2 | EC50 | = | 4.31 | uM | ALA5143791 | 5.37 | nM | Human immunodeficiency virus 1 | ||
14. | ALA5191897 | Q-a2 | EC50 | = | 0.69 | uM | ALA5143790 | 6.16 | nM | Human immunodeficiency virus 1 | ||
15. | ALA5191897 | Q-a2 | CLH | = | 759.5 | ml/min.kg | ALA5143789 | mL.min-1.kg-1 |